-
Product Insights
Enbridge Vesper Solar PV Park
Enbridge Vesper Solar PV Park is a solar PV project located in Wisconsin, United States. The project is owned and developed by Enbridge Inc. The project is currently under construction. Empower your strategies with our Enbridge Vesper Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
Vesper Hornet Solar PV Park
Vesper Hornet Solar PV Park is a solar PV project located in Texas, United States. The project is owned and being developed by Vesper Energy Corp. The project is at the permitting stage. Empower your strategies with our Vesper Hornet Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Vesper Energy Axton Solar PV Park
Vesper Energy Axton Solar PV Park is a solar PV project located in Virginia, United States. The project is owned and being developed by Vesper Energy Corp. The project is at the permitting stage. Empower your strategies with our Vesper Energy Axton Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends...
-
Thematic Analysis
NewWeb3 – Thematic Intelligence
Web3 is an ideology that refers to the next iteration of the internet built on blockchain. It promises a mix of peer-to-peer (P2P) communication channels and decentralized governance, leading the internet’s transition from an information-centric model to a user-centric model. Web3 aims to give users the ability to create, own, and monetize their content and manage the use of their data. This will be stored on blockchains instead of on third-party servers.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VES-001 in Frontotemporal Dementia (FTD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VES-001 in Frontotemporal Dementia (FTD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VES-001 in Frontotemporal Dementia (FTD) Drug Details: VES-001 is under development...
-
Product Insights
Dysmenorrhea – Drugs In Development, 2023
Global Markets Direct’s, ‘Dysmenorrhea - Drugs In Development, 2023’, provides an overview of the Dysmenorrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dysmenorrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Addictive Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Addictive Disorders - Drugs In Development, 2023’, provides an overview of the Addictive Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Addictive Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Pancreatic Diseases – Drugs In Development, 2023
Global Markets Direct’s, ‘Pancreatic Diseases - Drugs In Development, 2023’, provides an overview of the Pancreatic Diseases pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatic Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Pancreatitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Pancreatitis - Drugs In Development, 2023’, provides an overview of the Pancreatitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pancreatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Brain Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Brain Cancer - Drugs In Development, 2023’, provides an overview of the Brain Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Brain Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...